RELIVION

THERAPY

Relivion MG goes beyond relieving migraine pain and associated symptoms with a complete program to support the management of migraine disease.

THE RELIVION
DEVICE

Relivion is a non-drug, wearable neuromodulation therapy that stimulates the six branches of the occipital and trigeminal nerves, which are responsible for migraines.

The therapy has demonstrated high clinical efficiency, previously only possible with invasive procedures.

The device is comfortably placed around the head, and the electrodes are accurately positioned above the target nerves for efficient stimulation. The treatment intensity level is adjustable for patient comfort.

STIMULATION OF THE
TRIGEMINAL NERVE

Relivion provides direct stimulation to four targeted branches of the trigeminal nerve which is responsible for pain, touch, and temperature sensations from your face to your brain.

STIMULATION OF THE OCCIPITAL NERVES

Relivion is the only wearable device that also concurrently stimulates two branches of the occipital nerve.

PATIENT APP

PHYSICIAN
DASHBOARD

WITH RELIVION,
YOU ARE NOT ALONE

You are connected into a robust therapy that is designed to achieve the best results possible.

Dedicated Support from Coaches

Comprehensive Tools & Technology

Connection to Trained
Prescribers

LIVE ON WITH RELIVION

CLINICAL DATA

Relivion MG is the first and only non-invasive neuromodulation technology that was able to demonstrate complete freedom of migraine symptoms.¹

Relivion MG is FDA cleared and is indicated for the acute treatment of migraine with or without aura in patients 18 years of age or older.

In the RIME Study, a total of 12 adverse events were reported. All events were mild to moderate (i.e. scalp numbness, itching, skin irritation and redness) and were anticipated and self-resolved. The RIME US Pivotal Study met all its endpoints with statistical significance.

RELIVION

THERAPY

Relivion MG goes beyond relieving migraine pain and associated symptoms with a complete program to support the management of migraine disease.

THE RELIVION
DEVICE

STIMULATION OF THE
TRIGEMINAL NERVE

STIMULATION OF THE OCCIPITAL NERVES

PATIENT APP

PHYSICIAN
DASHBOARD

WITH RELIVION,
YOU ARE NOT ALONE

Dedicated Support from Coaches

LIVE ON WITH RELIVION

CLINICAL DATA

Relivion MG is FDA cleared and is indicated for the acute treatment of migraine with or without aura in patients 18 years of age or older.

In the RIME Study, a total of 12 adverse events were reported. All events were mild to moderate (i.e. scalp numbness, itching, skin irritation and redness) and were anticipated and self-resolved. The RIME US Pivotal Study met all its endpoints with statistical significance.

REFERENCE

TRY RELIVION FOR 60-DAYS AND FEEL THE DIFFERENCE.

RELIVION

THERAPY

Relivion MG goes beyond relieving migraine pain and associated symptoms with a complete program to support the management of migraine disease.

THE RELIVION DEVICE

STIMULATION OF THE TRIGEMINAL NERVE

STIMULATION OF THE OCCIPITAL NERVES

PATIENT APP

PHYSICIAN DASHBOARD

WITH RELIVION, YOU ARE NOT ALONE

Dedicated Support from Coaches

LIVE ON WITH RELIVION

CLINICAL DATA

Relivion MG is FDA cleared and is indicated for the acute treatment of migraine with or without aura in patients 18 years of age or older.

In the RIME Study, a total of 12 adverse events were reported. All events were mild to moderate (i.e. scalp numbness, itching, skin irritation and redness) and were anticipated and self-resolved. The RIME US Pivotal Study met all its endpoints with statistical significance.

REFERENCE

TRY RELIVION FOR 60-DAYS AND FEEL THE DIFFERENCE.

THE RELIVION
DEVICE

STIMULATION OF THE
TRIGEMINAL NERVE

PHYSICIAN
DASHBOARD

WITH RELIVION,
YOU ARE NOT ALONE